Halozyme Therapeutics Launches Halo Collar 5: Next-Level GPS Technology for Pet Safety
- Halo Therapeutics launched the Halo Collar 5 on September 18, 2025, featuring advanced GPS tracking technology for pets.
- The collar includes an escape-proof system, promoting humane training methods and prioritizing dogs' mental well-being.
- Halo is enhancing pet care with the Halo Health™ app, providing insights into dogs' physical health and activity data.
Halo Collar 5: Revolutionizing Pet Safety with Advanced Technology
Halo, a leading innovator in pet safety, introduces the Halo Collar 5, which sets a new standard in GPS tracking technology for dogs. Launched on September 18, 2025, this collar is designed with AlwaysOn™ GPS tracking that provides real-time location updates without compromising on battery life, even in challenging environments. Unlike conventional collars, the Halo Collar 5 processes 20 GPS updates per second, ensuring unmatched precision and a response time that is 20 times faster than its competitors. This level of accuracy allows pet owners to track their dogs with confidence, knowing they can locate their pets swiftly and efficiently.
One of the most significant features of the Halo Collar 5 is its patented escape-proof protection system. This innovative design not only prevents dogs from straying too far but also guides them back to safety by using positive reinforcement techniques instead of negative corrections. This approach aligns with modern training philosophies, prioritizing a dog's mental well-being while ensuring their safety. Co-founder Ken Ehrman highlights this commitment to creating safer off-leash experiences, reflecting the broader trend in the pet industry towards humane and effective training methods.
The collar caters to dogs of all sizes, with an adjustable fit ranging from 8 inches to 30.5 inches in neck size, accommodating a diverse range of breeds and ensuring comfort. Available in five vibrant colors—Blaze, Midnight Blue, Graphite, Orchid, and Sunburst—the Halo Collar 5 combines functionality with style. Moreover, the collar features dual-chip WiFi and Bluetooth technology to enhance connectivity, improving range and stability while extending battery life to an impressive 48 hours on a single charge.
In addition to the innovative collar, Halo is also enhancing its app with the introduction of Halo Health™, which offers pet owners valuable insights into their dog’s physical health. This feature provides daily activity data and new functions aimed at promoting pet well-being, reflecting Halo's mission to prioritize not just safety, but also the overall health of pets. By integrating advanced technology with a focus on the physical and emotional needs of dogs, Halo Therapeutics is making significant strides in the pet care industry.
Overall, the Halo Collar 5 represents a substantial advancement in pet safety technology, reinforcing Halo's commitment to enhancing the lives of pets and their owners alike. With its combination of cutting-edge features and a focus on humane training methods, Halo is poised to lead the charge in the evolving landscape of pet care.
Related Cashu News

Bristol-Myers Squibb's Reclassification Enhances Growth Potential in Defensive Investment Strategy
Bristol-Myers Squibb Company (Ticker: BMY) undergoes a key reclassification across the Russell indexes, marking a transformative moment for the company. Moving to the Russell 1000 Defensive and Russel…

Vertex Pharmaceuticals' Casgevy Gains FDA Approval for Expanded Sickle Cell Disease Treatment Options
Vertex Pharmaceuticals (Ticker: VRTX) receives a significant boost in its ongoing battle against sickle cell disease with the recent FDA approval of an expanded label for its gene therapy product, Cas…

Gilead Sciences Gains FDA Approval for Trodelvy in First-Line Triple-Negative Breast Cancer Treatment
Gilead Sciences (Ticker: GILD) makes significant strides in oncology therapy with the recent approval of its drug Trodelvy for patients with unresectable or metastatic triple-negative breast cancer. T…

Merck Advances HIV Treatment and Faces Regulatory Scrutiny Amidst Market Success
Merck & Co. (Ticker: MRK) has recently made significant strides in the pharmaceutical landscape, particularly with its advancements in HIV treatment. The company's innovative drug, IDVYNSO, has receiv…